Nishimura-Kinoshita Naoko, Ohata Yasuhisa, Sawai Hiromi, Izawa Masako, Takeyari Shinji, Kubota Takuo, Omae Yosuke, Ozono Keiichi, Tokunaga Katsushi, Hamajima Takashi
Department of Pediatrics, Tango Central Hospital, Kyoto, Japan.
Department of Endocrinology and Metabolism, Aichi Children's Health and Medical Center, Aichi, Japan.
Clin Pediatr Endocrinol. 2023;32(3):161-167. doi: 10.1297/cpe.2022-0071. Epub 2023 Apr 14.
Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare, inherited autosomal recessive disorder caused by fibroblast growth factor-23 (), N-acetylgalactosaminyltransferase 3 (), or Klotho () gene variants. Here, we report the case of a Japanese boy who presented with a mass in his left elbow at the age of three. Laboratory test results of the patient revealed normocalcemia (10.3 mg/dL) and hyperphosphatemia (8.7 mg/dL); however, despite hyperphosphatemia, serum intact FGF23 level was low, renal tubular reabsorption of phosphate (TRP) level was inappropriately increased, and 1,25-dihydroxyvitamin D (1,25(OH)D) level was inappropriately normal. Genetic analysis revealed maternal uniparental disomy (UPD) of chromosome 2, which included a novel variant (c.1780-1G>C). Reverse transcription-polymerase chain reaction (RT-PCR) analysis of mRNA confirmed that this variant resulted in the destruction of exon 11. We resected the mass when the patient was five years old, owing to its gradual enlargement. No relapse or new pathological lesions were observed four years after tumor resection. This is the first case report of a Japanese patient with HFTC associated with a novel variant, as well as the first case of HFTC caused by maternal UPD of chromosome 2 that includes the variant.
高磷血症性家族性肿瘤性钙化症(HFTC)是一种罕见的常染色体隐性遗传性疾病,由成纤维细胞生长因子23(FGF23)、N - 乙酰半乳糖胺基转移酶3(GALNT3)或klotho(KL)基因变异引起。在此,我们报告一例日本男孩病例,该男孩三岁时左肘部出现肿块。患者的实验室检查结果显示血钙正常(10.3mg/dL),血磷升高(8.7mg/dL);然而,尽管血磷升高,但血清完整FGF23水平较低,肾小管对磷的重吸收(TRP)水平异常升高,且1,25 - 二羟维生素D(1,25(OH)D)水平异常正常。基因分析显示2号染色体存在母源性单亲二体(UPD),其中包括一个新的GALNT3变异(c.1780 - 1G>C)。对GALNT3 mRNA进行逆转录 - 聚合酶链反应(RT - PCR)分析证实,该变异导致第11外显子破坏。由于肿块逐渐增大,我们在患者五岁时将其切除。肿瘤切除四年后未观察到复发或新的病理病变。这是首例关于日本HFTC患者伴有新的GALNT3变异的病例报告,也是首例由包含该变异的2号染色体母源性UPD引起的HFTC病例。